Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion type Assertion NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_head.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion evidence source_evidence_literature NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion SIO_000772 20648626 NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion wasDerivedFrom befree-20140225 NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion wasGeneratedBy ECO_0000203 NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.